Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 2
2013 1
2015 1
2017 1
2018 3
2019 1
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.
Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, Gasperini C, Marfia GA, Millefiorini E, Nociti V, Pontecorvo S, Pozzilli C, Ruggieri S, Salvetti M, Sgarlata E, Mirabella M. Prosperini L, et al. Neurology. 2018 Jul 10;91(2):e153-e161. doi: 10.1212/WNL.0000000000005772. Epub 2018 Jun 6. Neurology. 2018. PMID: 29875218 Clinical Trial.
Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis.
Tommasin S, De Luca F, Ferrante I, Gurreri F, Castelli L, Ruggieri S, Prosperini L, Pantano P, Pozzilli C, De Giglio L. Tommasin S, et al. J Neuropsychol. 2020 Sep;14(3):370-383. doi: 10.1111/jnp.12197. Epub 2019 Nov 14. J Neuropsychol. 2020. PMID: 31729168
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study.
Mirabella M, Prosperini L, Lucchini M, Boffa L, Borriello G, Buscarinu MC, Centonze D, Cortese A, De Fino C, De Giglio L, Elia G, Fantozzi R, Ferraro E, Francia A, Galgani S, Gasperini C, Haggiag S, Landi D, Marfia GA, Millefiorini E, Monteleone F, Nociti V, Salvetti M, Sgarlata E, Pozzilli C. Mirabella M, et al. CNS Drugs. 2018 Oct;32(10):963-970. doi: 10.1007/s40263-018-0543-3. CNS Drugs. 2018. PMID: 30022464 Clinical Trial.
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.
Prosperini L, Annovazzi P, Boffa L, Buscarinu MC, Gallo A, Matta M, Moiola L, Musu L, Perini P, Avolio C, Barcella V, Bianco A, Farina D, Ferraro E, Pontecorvo S, Granella F, Grimaldi LME, Laroni A, Lus G, Patti F, Pucci E, Pasca M, Sarchielli P; Italian Alemtuzumab Study Group. Prosperini L, et al. J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26. J Neurol. 2018. PMID: 30259178 Clinical Trial.
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis.
Prosperini L, Mancinelli C, Haggiag S, Cordioli C, De Giglio L, De Rossi N, Galgani S, Rasia S, Ruggieri S, Tortorella C, Pozzilli C, Gasperini C. Prosperini L, et al. J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):271-277. doi: 10.1136/jnnp-2019-322348. Epub 2020 Jan 23. J Neurol Neurosurg Psychiatry. 2020. PMID: 31974130 Clinical Trial.
Multiple Sclerosis Treatment and Melanoma Development.
Carbone ML, Lacal PM, Messinese S, De Giglio L, Pozzilli C, Persechino S, Mazzanti C, Failla CM, Pagnanelli G. Carbone ML, et al. Int J Mol Sci. 2020 Apr 22;21(8):2950. doi: 10.3390/ijms21082950. Int J Mol Sci. 2020. PMID: 32331328 Free PMC article.
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis.
D'Amico E, Zanghì A, Sciandra M, Lanzillo R, Callari G, Cortese A, Lus G, Lucchini M, Buccafusca M, Bonavita S, Gallo A, Curti E, Gajofatto A, Signoriello E, Bisecco A, Gobbin F, Ferrò MT, Ferrazzano G, Sparaco M, Valentino P, Mirabella M, Granella F, Bresciamorra V, Grimaldi LME, Patti F; ITALIAN-DIME-TERI group. D'Amico E, et al. J Neurol. 2020 Oct;267(10):3008-3020. doi: 10.1007/s00415-020-09959-1. Epub 2020 Jun 6. J Neurol. 2020. PMID: 32506391
National guidelines for the prevention and clinical management of dental trauma in individuals during their developmental age.
Cagetti MG, Federici A, Iannetti G, Gherlone E, Mazza C, Majorana A, Marcoli PA, Montagna MT, Munizzi MR, Nardone M, Pinchi V, Pizzi S, Polimeni A, Zampogna S, Strohmenger L, De Filippo S, De Giglio O, Mastroberardino S, Aloe M, Quaranta A, Talarico V; Italian Ministry of Health. Cagetti MG, et al. Ann Ig. 2013 Nov-Dec;25(6):459-84. Ann Ig. 2013. PMID: 24284533 No abstract available.
Premorbid functional reserve modulates the effect of rehabilitation in multiple sclerosis.
Castelli L, De Giglio L, Haggiag S, Traini A, De Luca F, Ruggieri S, Prosperini L. Castelli L, et al. Neurol Sci. 2020 May;41(5):1251-1257. doi: 10.1007/s10072-019-04237-z. Epub 2020 Jan 9. Neurol Sci. 2020. PMID: 31919697
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study.
Prosperini L, Mancinelli CR, Solaro CM, Nociti V, Haggiag S, Cordioli C, De Giglio L, De Rossi N, Galgani S, Rasia S, Ruggieri S, Tortorella C, Capra R, Mirabella M, Gasperini C. Prosperini L, et al. Neurotherapeutics. 2020 Mar 31. doi: 10.1007/s13311-020-00847-0. Online ahead of print. Neurotherapeutics. 2020. PMID: 32236822
19 results
Jump to page
Feedback